Clinical trial
Clinical Trial for the Prevention of Vasovagal Syncope
NCT00118482 · University of Calgary, Other · Completed
Key facts
| NCT number | NCT00118482 |
|---|---|
| Title | Clinical Trial for the Prevention of Vasovagal Syncope |
| Official title | A Randomized Clinical Trial of Fludrocortisone for Vasovagal Syncope: The Second Prevention of Syncope Trial (POST II) |
| Lead sponsor | University of Calgary, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Syncope, Vasovagal, Neurally-Mediated |
| Intervention type | Drug |
| Interventions | fludrocortisone acetate |
| Enrollment | 213 |
| Start date | May 1, 2005 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Jul 11, 2005 |
| Last update posted | Oct 15, 2019 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: